Zhongnan Medical Journal Press

Home Results

A total of 3 result was found. Results that relate to Sacubitril/Valsartan

Cost-utility analysis of sacubitril/valsartan, dapagliflozin and empagliflozin in heart failure with reduced ejection fraction

Published on Chinese Journal of Pharmacoepidemiology 2023,32(8):878-885.
3763 times 1099 times

Dan-Dan LU Sheng-Xiang WANG Shan LU Dan PAN Li-Yuan SHI Fei-Chuang Jing2

Heart failure with reduced ejection fraction Sacubitril/valsartan Dapagliflozin Empagliflozin Markov model Cost-utility analysis
Details
Efficacy and safety of sacubitril/valsartan in the treatment of atrial fibrillation after ablation: a Meta-analysis

Published on New Medicine 2024,34(8):916-926.
3506 times 1014 times

BI Longfei LIU Yao YU Dan DAN Xuechuan LI Kui

Sacubitril/valsartan Atrial fibrillation Angiotensin converting enzyme inhibitors Angiotensin receptor blockers Ablation Meta-analysis
Details
A case report of acute kidney injury caused by semaglutide in combination with multiple medications

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):835-840.
837 times 123 times

GU Jiamei TANG Chenquan JIANG Yi YIN Hao FENG Chen XUE Yi

Semaglutide Metformin Dapagliflozin Sacubitril/Valsartan Acute kidney injury Adverse reactions
Details